NeutriSci International Inc. (NRXCF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
-0.0013 (-99.92%)
At close: Aug 15, 2024
NeutriSci International Revenue
NeutriSci International had revenue of 2.73K CAD in the quarter ending September 30, 2023, a decrease of -47.03%. This brings the company's revenue in the last twelve months to 59.98K, down -86.13% year-over-year. In the year 2022, NeutriSci International had annual revenue of 457.75K with 465.86% growth.
Revenue (ttm)
59.98K CAD
Revenue Growth
-86.13%
P/S Ratio
14.69
Revenue / Employee
n/a
Employees
n/a
Market Cap
651.26K USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 457.75K | 376.86K | 465.86% |
Dec 31, 2021 | 80.89K | 6.32K | 8.48% |
Dec 31, 2020 | 74.57K | -21.97K | -22.75% |
Dec 31, 2019 | 96.54K | 13.88K | 16.79% |
Dec 31, 2018 | 82.66K | -68.41K | -45.28% |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sep 30, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Glass House Brands | 200.90M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Silence Therapeutics | 43.26M |
NeutriSci International News
- 3 years ago - NeutriSci Announces Successful Completion of R&D in Preparation for Launch of Its Functional Mushroom Product Line - Accesswire
- 3 years ago - NeutriSci Receives Additional Purchase Order and Deposit from Tabletz Distribution Partner - Accesswire
- 3 years ago - NeutriSci Arranges Strategic Financing with Tabletz and Exercise of Warrants - Accesswire
- 4 years ago - Neutrisci Provides Update on Tabletz Developments - Accesswire
- 4 years ago - Neutrisci Provides Update on Tabletz and Previously Announced Project Development - Accesswire
- 4 years ago - NeutriSci Provides Update On Biople Product Launch In Japan - Accesswire
- 4 years ago - Neutrisci Ships Tabletz Rush Order to #1 CBD Retailer in Japan - Accesswire
- 4 years ago - NeutriSci Completes R&D and Expands Product Selection to Include Beverages - Accesswire